{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:17:18Z","timestamp":1789348638195,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>To date, evidences with high evidence-level evaluating the association between liver diseases and hidradenitis suppurativa was lacking. Given that inconsistency exists in some of the previous observational studies, evaluating the prevalence of liver diseases in HS patients could potentially serve as a reference of future guidelines for HS comorbidity screening. The aim of the current study was to evaluate potential association between hidradenitis suppurativa and liver diseases and provide integrated evidences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A search in PubMed, Web of Science and Embase based on the syntaxes \u2018\u2018hidradenitis suppurativa\u2019\u2019 or \u2018\u2018acne inversa\u2019\u2019 with \u201ccomorbidities\u201d, \u201cliver diseases\u201d, \u201cfatty liver\u201d or \u201chepatitis\u201d was performed. Observational studies evaluating epidemiological association between hidradenitis suppurativa and the risk of all liver diseases, including specific diseases as non-alcoholic fatty liver disease, hepatitis B, hepatitis C were targeted to be extracted in this systematic review and meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Within the initial 702 records, there were finally 8 real-world observational studies extracted. Results suggest that patients with HS are associated with all liver diseases (OR= 1.50; 95% CI, 1.27, 1.76), non-alcoholic fatty liver disease (OR= 1.78; 95% CI, 1.28, 2.48) and hepatitis B (OR=1.48; 95% CI, 1.12, 1.94), but not hepatitis C (OR= 1.27; 95% CI, 0.78, 2.07). HS patients were associated with significantly increased risk of liver diseases, especially the risk of non-alcoholic fatty liver disease and hepatitis B.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Clinicians should be alert to the clinical relationship while caring people with hidradenitis suppurativa and the screening of liver function should be recommended to HS patients. <\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42022296034.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.959691","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T08:21:05Z","timestamp":1671006065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences"],"prefix":"10.3389","volume":"13","author":[{"given":"Shuo-Yan","family":"Gau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chieh","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Sheng-Kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Che","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15578","article-title":"Hepatitis b and c among patients with hidradenitis suppurativa: A population-based study","volume":"61","author":"Cohen","year":"2021","journal-title":"Int J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of hidradenitis suppurativa: A systematic review and meta-regression analysis","volume":"157","author":"Jfri","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the us and canadian hidradenitis suppurativa foundations","volume":"86","author":"Garg","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.08.014","article-title":"Cross-sectional study reveals reduced odds of allergies in people with hidradenitis suppurativa","volume":"85","author":"Schell","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840106","article-title":"Bidirectional association between psoriasis and nonalcoholic fatty liver disease: Real-world evidence from two longitudinal cohort studies","volume":"13","author":"Gau","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01755-0","article-title":"Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: An updated systematic review and meta-analysis of observational studies","volume":"45","author":"Bellinato","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010377","article-title":"Bullous pemphigoid associated with chronic hepatitis c virus infection in a hepatitis b virus endemic area: A case report","volume":"97","author":"Jang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00682-5","article-title":"Risk for hepatitis b virus reactivation in patients with psoriasis treated with biological agents: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01195","article-title":"Immunity and fibrogenesis: The role of th17\/il-17 axis in hbv and hcv-induced chronic hepatitis and progression to cirrhosis","volume":"8","author":"Paquissi","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"Il-1 family cytokine pathways underlying nafld: Towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13449","article-title":"Il-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaip.2021.09.021","article-title":"Higher risk of hyperthyroidism in people with asthma: Evidence from a nationwide, population-based cohort study","volume":"10","author":"Gau","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.830729","article-title":"Higher dementia risk in people with gastroesophageal reflux disease: A real-world evidence","volume":"14","author":"Gau","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102776","article-title":"Increased risk of hypothyroidism in people with asthma: Evidence from a real-world population-based study","volume":"11","author":"Huang","year":"2022","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00392","article-title":"Patients with rheumatoid arthritis increased risk of developing osteoarthritis: A nationwide population-based cohort study in taiwan","volume":"7","author":"Lee","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18093","article-title":"Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in u.S. children and adults","volume":"182","author":"Lee","year":"2020","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15071","article-title":"Prevalence and comorbidities associated with hidradenitis suppurativa in korea: A nationwide population-based study","volume":"32","author":"Lee","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16423","article-title":"Increased risk of renal diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis","author":"Gau","year":"2022","journal-title":"Int J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16484","article-title":"Hyperthyroidism and hypothyroidism in patients with hidradenitis suppurativa: A systematic review and meta-analysis","author":"Gau","year":"2022","journal-title":"Int J Dermatol"},{"key":"B21","unstructured":"Wells GSB\n            O\u2019ConnellD\n            RobertsonJ\n          The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analysis2018"},{"key":"B22","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022)","author":"Higgins","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the united states: A claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15764","article-title":"High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors","volume":"33","author":"Duran-Vian","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"adv00239","DOI":"10.2340\/00015555-3597","article-title":"Hidradenitis suppurativa is associated with non-alcoholic fatty liver disease: A cross-sectional study","volume":"100","author":"Gonzalez-Villanueva","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"AB25","DOI":"10.1016\/j.jaad.2019.06.129","article-title":"Autoimmune comorbidities of hidradenitis suppurativa in us adults and children","volume":"81","author":"Narla","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"AB223","DOI":"10.1016\/j.jaad.2020.06.981","article-title":"18858 examining the association between hidradenitis suppurativa and gastrointestinal disorders","volume":"83","author":"Raiker","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.05.019","article-title":"From non-alcoholic fatty liver disease (nafld) to metabolic-associated fatty liver disease (mafld): A journey over 40 years","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32499","article-title":"Are there outcomes differences between non-alcoholic fatty liver disease (nafld) and metabolic associated fatty liver disease (mafld)","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden","volume":"179","author":"Prussick","year":"2018","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.0141","article-title":"Association of hidradenitis suppurativa with t helper 1\/t helper 17 phenotypes: A semantic map analysis","volume":"154","author":"Thomi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21060","article-title":"Il-17ra blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum","volume":"187","author":"Navrazhina","year":"2022","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/12034754211035667","article-title":"Treatment outcomes of il-17 inhibitors in hidradenitis suppurativa: A systematic review","volume":"26","author":"Kashetsky","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-8-40","article-title":"Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis b virus infection: Il-17 in hbv infection","volume":"8","author":"Du","year":"2013","journal-title":"Diagn Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.798417","article-title":"Correlation of adiponectin gene polymorphisms rs266729 and rs3774261 with risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.814209","article-title":"Non-alcoholic fatty liver disease in hiv\/hbv patients - a metabolic imbalance aggravated by antiretroviral therapy and perpetuated by the hepatokine\/adipokine axis breakdown","volume":"13","author":"Iacob","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T08:21:10Z","timestamp":1671006070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2022.959691"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.959691","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"article-number":"959691"}}